Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSMUSG00000055116.7 | Arntl |
Tfe3
|
ENSMUSG00000000134.11 | Tfe3 |
Mlx
|
ENSMUSG00000017801.9 | Mlx |
Mitf
|
ENSMUSG00000035158.9 | Mitf |
Mlxipl
|
ENSMUSG00000005373.7 | Mlxipl |
Tfec
|
ENSMUSG00000029553.7 | Tfec |
Gene | Promoter | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Arntl | chr7_113261901_113262194 | 22293 | 0.164687 | 0.89 | 1.6e-02 | Click! |
Arntl | chr7_113214662_113214859 | 7203 | 0.227269 | -0.89 | 1.7e-02 | Click! |
Arntl | chr7_113250583_113250734 | 10904 | 0.198618 | -0.85 | 3.4e-02 | Click! |
Arntl | chr7_113311901_113312065 | 6563 | 0.157256 | -0.77 | 7.1e-02 | Click! |
Arntl | chr7_113261012_113261214 | 21359 | 0.167518 | -0.76 | 8.1e-02 | Click! |
Mitf | chr6_97806549_97806791 | 382 | 0.879141 | -0.88 | 2.1e-02 | Click! |
Mitf | chr6_97806205_97806539 | 680 | 0.729392 | -0.84 | 3.5e-02 | Click! |
Mitf | chr6_98003284_98003457 | 11449 | 0.279352 | -0.82 | 4.6e-02 | Click! |
Mitf | chr6_97962459_97962619 | 21621 | 0.240765 | 0.74 | 9.5e-02 | Click! |
Mitf | chr6_98001659_98001821 | 9819 | 0.284263 | -0.68 | 1.4e-01 | Click! |
Mlx | chr11_101087414_101087768 | 287 | 0.776091 | -0.89 | 1.8e-02 | Click! |
Mlx | chr11_101086894_101087064 | 298 | 0.764162 | -0.70 | 1.2e-01 | Click! |
Mlx | chr11_101086153_101086550 | 926 | 0.319383 | -0.61 | 2.0e-01 | Click! |
Mlx | chr11_101091496_101091647 | 1909 | 0.145960 | -0.58 | 2.3e-01 | Click! |
Mlx | chr11_101087163_101087322 | 35 | 0.937431 | 0.46 | 3.5e-01 | Click! |
Mlxipl | chr5_135109145_135109303 | 2306 | 0.160515 | 0.88 | 2.2e-02 | Click! |
Mlxipl | chr5_135110102_135110316 | 3291 | 0.128203 | 0.84 | 3.5e-02 | Click! |
Mlxipl | chr5_135108021_135108189 | 1187 | 0.299834 | 0.81 | 5.3e-02 | Click! |
Mlxipl | chr5_135137189_135137342 | 3634 | 0.127204 | 0.77 | 7.2e-02 | Click! |
Mlxipl | chr5_135107073_135107233 | 235 | 0.858383 | -0.77 | 7.2e-02 | Click! |
Tfe3 | chrX_7766214_7766424 | 1667 | 0.176485 | -0.94 | 5.3e-03 | Click! |
Tfe3 | chrX_7762523_7762703 | 27 | 0.940346 | 0.66 | 1.5e-01 | Click! |
Tfe3 | chrX_7763587_7763814 | 243 | 0.820427 | 0.56 | 2.5e-01 | Click! |
Tfe3 | chrX_7764171_7764326 | 161 | 0.884460 | 0.47 | 3.4e-01 | Click! |
Tfe3 | chrX_7765776_7766087 | 1279 | 0.233622 | 0.45 | 3.7e-01 | Click! |
Tfec | chr6_16884011_16884167 | 14310 | 0.232696 | 0.93 | 6.8e-03 | Click! |
Tfec | chr6_16891836_16892176 | 6393 | 0.253812 | 0.86 | 2.6e-02 | Click! |
Tfec | chr6_16898373_16898552 | 21 | 0.983453 | 0.78 | 6.7e-02 | Click! |
Tfec | chr6_16835766_16835917 | 578 | 0.821711 | -0.55 | 2.6e-01 | Click! |
Tfec | chr6_16856012_16856182 | 10101 | 0.255345 | 0.42 | 4.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_81199680_81199982 | 81.95 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
36235 |
0.17 |
chr18_81199291_81199673 | 47.48 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
36584 |
0.17 |
chr16_45970303_45970469 | 28.41 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
16788 |
0.15 |
chr7_26304675_26304844 | 24.41 |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
2410 |
0.19 |
chr7_26832827_26833002 | 23.09 |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
2391 |
0.25 |
chr5_122647730_122647905 | 22.27 |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
2607 |
0.19 |
chr2_163037922_163038123 | 17.74 |
Ift52 |
intraflagellar transport 52 |
15579 |
0.11 |
chr9_42464224_42464407 | 17.00 |
Tbcel |
tubulin folding cofactor E-like |
2854 |
0.24 |
chr9_42464439_42464590 | 16.77 |
Tbcel |
tubulin folding cofactor E-like |
3053 |
0.23 |
chr5_36043248_36043399 | 16.24 |
Afap1 |
actin filament associated protein 1 |
56318 |
0.14 |
chr2_163038300_163038466 | 15.87 |
Ift52 |
intraflagellar transport 52 |
15940 |
0.11 |
chr10_89813381_89813532 | 14.74 |
Uhrf1bp1l |
UHRF1 (ICBP90) binding protein 1-like |
1585 |
0.4 |
chr2_163038133_163038284 | 14.47 |
Ift52 |
intraflagellar transport 52 |
15765 |
0.11 |
chr18_6034031_6034182 | 14.33 |
Arhgap12 |
Rho GTPase activating protein 12 |
601 |
0.78 |
chr2_7260244_7260638 | 13.63 |
Gm24340 |
predicted gene, 24340 |
89656 |
0.09 |
chr4_128946816_128947003 | 13.54 |
Gm15904 |
predicted gene 15904 |
10904 |
0.15 |
chr6_71235183_71235374 | 13.33 |
Smyd1 |
SET and MYND domain containing 1 |
18404 |
0.1 |
chr1_40217644_40217810 | 13.27 |
Il1r1 |
interleukin 1 receptor, type I |
7353 |
0.21 |
chr13_101753788_101753966 | 12.85 |
Gm36638 |
predicted gene, 36638 |
672 |
0.73 |
chr7_100937600_100937760 | 12.27 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
5573 |
0.15 |
chr5_139358617_139359046 | 11.78 |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
4255 |
0.13 |
chr12_71429918_71430089 | 11.69 |
1700083H02Rik |
RIKEN cDNA 1700083H02 gene |
45795 |
0.12 |
chr2_163037706_163037864 | 10.89 |
Ift52 |
intraflagellar transport 52 |
15342 |
0.11 |
chr4_128635594_128635931 | 10.80 |
Gm12958 |
predicted gene 12958 |
1709 |
0.31 |
chr18_76542608_76542770 | 10.52 |
Gm31933 |
predicted gene, 31933 |
90181 |
0.09 |
chr18_78147947_78148101 | 10.33 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
5905 |
0.25 |
chr4_124670340_124670505 | 10.15 |
Gm2164 |
predicted gene 2164 |
13253 |
0.09 |
chr2_173531317_173531484 | 10.08 |
1700021F07Rik |
RIKEN cDNA 1700021F07 gene |
8814 |
0.21 |
chr12_84290566_84290750 | 9.93 |
Ptgr2 |
prostaglandin reductase 2 |
5245 |
0.13 |
chr5_66114850_66115151 | 9.90 |
Rbm47 |
RNA binding motif protein 47 |
16809 |
0.11 |
chr1_88316757_88316908 | 9.87 |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
2081 |
0.23 |
chr5_144248287_144248466 | 9.86 |
2900089D17Rik |
RIKEN cDNA 2900089D17 gene |
1870 |
0.23 |
chr19_33489637_33489788 | 9.82 |
Lipo5 |
lipase, member O5 |
16521 |
0.14 |
chr8_123736984_123737175 | 9.70 |
Gm45781 |
predicted gene 45781 |
1937 |
0.14 |
chr9_103503756_103503910 | 9.68 |
Tmem108 |
transmembrane protein 108 |
10222 |
0.11 |
chr2_48442189_48442365 | 9.60 |
Gm13481 |
predicted gene 13481 |
14968 |
0.23 |
chr19_33480626_33480777 | 9.58 |
Lipo5 |
lipase, member O5 |
7510 |
0.16 |
chr6_91599085_91599288 | 9.54 |
Gm45218 |
predicted gene 45218 |
46 |
0.97 |
chr12_84290810_84291009 | 9.53 |
Ptgr2 |
prostaglandin reductase 2 |
5496 |
0.13 |
chr13_59011529_59011736 | 9.37 |
Gm34245 |
predicted gene, 34245 |
66664 |
0.09 |
chr8_123661868_123662019 | 9.34 |
Rhou |
ras homolog family member U |
8014 |
0.05 |
chr7_45574063_45574214 | 9.22 |
Bcat2 |
branched chain aminotransferase 2, mitochondrial |
962 |
0.22 |
chr2_163038512_163038663 | 9.21 |
Mybl2 |
myeloblastosis oncogene-like 2 |
16100 |
0.11 |
chr13_31619653_31619819 | 9.21 |
Gm11378 |
predicted gene 11378 |
568 |
0.66 |
chr7_145056434_145056606 | 9.20 |
Gm45181 |
predicted gene 45181 |
106476 |
0.05 |
chr4_128946455_128946665 | 9.00 |
Gm15904 |
predicted gene 15904 |
10555 |
0.15 |
chr5_137052026_137052177 | 8.97 |
Ap1s1 |
adaptor protein complex AP-1, sigma 1 |
5966 |
0.11 |
chr15_38328549_38328722 | 8.94 |
Gm35248 |
predicted gene, 35248 |
16342 |
0.14 |
chr5_151408230_151408394 | 8.85 |
1700028E10Rik |
RIKEN cDNA 1700028E10 gene |
1786 |
0.32 |
chr1_131123350_131123513 | 8.85 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
14814 |
0.12 |
chr8_61585782_61586047 | 8.80 |
Palld |
palladin, cytoskeletal associated protein |
5225 |
0.3 |
chr8_31524559_31524710 | 8.77 |
Gm45303 |
predicted gene 45303 |
32658 |
0.2 |
chr17_86458349_86458750 | 8.65 |
Prkce |
protein kinase C, epsilon |
32013 |
0.19 |
chr10_17551883_17552066 | 8.62 |
Gm47770 |
predicted gene, 47770 |
25060 |
0.17 |
chr11_31824504_31824681 | 8.61 |
D630024D03Rik |
RIKEN cDNA D630024D03 gene |
68 |
0.97 |
chr8_40606544_40606745 | 8.57 |
Mtmr7 |
myotubularin related protein 7 |
16130 |
0.17 |
chr18_46997805_46997956 | 8.56 |
Gm22791 |
predicted gene, 22791 |
12399 |
0.15 |
chr11_98775529_98775744 | 8.53 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
303 |
0.81 |
chr5_30551378_30551537 | 8.52 |
Cib4 |
calcium and integrin binding family member 4 |
5621 |
0.14 |
chr1_21253032_21253214 | 8.49 |
Gsta3 |
glutathione S-transferase, alpha 3 |
398 |
0.75 |
chr4_10924259_10924435 | 8.44 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
22261 |
0.14 |
chr17_56476460_56476653 | 8.29 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
73 |
0.96 |
chr11_98772948_98773272 | 8.19 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2223 |
0.16 |
chr14_56558202_56558361 | 8.16 |
Cenpj |
centromere protein J |
5796 |
0.17 |
chr17_85858174_85858325 | 8.13 |
Gm29418 |
predicted gene 29418 |
34205 |
0.19 |
chr7_27478150_27478347 | 8.11 |
Sertad3 |
SERTA domain containing 3 |
4480 |
0.1 |
chr19_36731471_36731641 | 8.09 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
5097 |
0.23 |
chr1_164212757_164212928 | 7.86 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
36204 |
0.1 |
chr9_65084518_65084694 | 7.84 |
Dpp8 |
dipeptidylpeptidase 8 |
8858 |
0.14 |
chr4_105633062_105633239 | 7.82 |
Gm12726 |
predicted gene 12726 |
54810 |
0.16 |
chr17_45825973_45826124 | 7.82 |
Gm35692 |
predicted gene, 35692 |
3725 |
0.21 |
chr8_46691365_46691641 | 7.80 |
Gm16675 |
predicted gene, 16675 |
48005 |
0.1 |
chr17_36848960_36849117 | 7.78 |
Trim26 |
tripartite motif-containing 26 |
3464 |
0.11 |
chr1_88040695_88040854 | 7.74 |
AC087801.1 |
UDP glycosyltransferase 1 family (Ytg1) pseudogene |
3174 |
0.1 |
chr13_81316709_81316876 | 7.74 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
26044 |
0.22 |
chr9_44289013_44289164 | 7.71 |
Abcg4 |
ATP binding cassette subfamily G member 4 |
473 |
0.55 |
chr7_80360672_80360826 | 7.67 |
Man2a2 |
mannosidase 2, alpha 2 |
838 |
0.42 |
chr6_125538615_125538782 | 7.67 |
Vwf |
Von Willebrand factor |
8076 |
0.18 |
chr8_108786077_108786260 | 7.67 |
Gm38042 |
predicted gene, 38042 |
48575 |
0.15 |
chr19_26730650_26730825 | 7.58 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
738 |
0.74 |
chr3_9610870_9611024 | 7.56 |
Zfp704 |
zinc finger protein 704 |
862 |
0.67 |
chr12_99371517_99371855 | 7.53 |
Gm47138 |
predicted gene, 47138 |
1773 |
0.26 |
chr18_46998104_46998255 | 7.49 |
Gm22791 |
predicted gene, 22791 |
12698 |
0.15 |
chr13_56354793_56354953 | 7.48 |
Gm10782 |
predicted gene 10782 |
8027 |
0.15 |
chr18_36508082_36508252 | 7.46 |
Hbegf |
heparin-binding EGF-like growth factor |
7200 |
0.14 |
chr7_130044668_130044823 | 7.37 |
Gm23847 |
predicted gene, 23847 |
9651 |
0.28 |
chr11_117877981_117878254 | 7.28 |
Tha1 |
threonine aldolase 1 |
4636 |
0.11 |
chr2_11458006_11458188 | 7.27 |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
24014 |
0.11 |
chr2_181232213_181232364 | 7.24 |
Helz2 |
helicase with zinc finger 2, transcriptional coactivator |
3466 |
0.11 |
chr8_115719178_115719339 | 7.22 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
11464 |
0.23 |
chr6_142451548_142451710 | 7.20 |
Gys2 |
glycogen synthase 2 |
21480 |
0.15 |
chr3_88424524_88424733 | 7.14 |
Slc25a44 |
solute carrier family 25, member 44 |
479 |
0.57 |
chr7_81453890_81454046 | 7.12 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
707 |
0.51 |
chr17_75330499_75330661 | 7.11 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
20424 |
0.26 |
chr8_26882732_26882894 | 7.10 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
118 |
0.97 |
chr7_45710445_45711101 | 7.09 |
Sphk2 |
sphingosine kinase 2 |
2670 |
0.09 |
chr14_120721195_120721346 | 7.00 |
Rpl19-ps5 |
ribosomal protein L19, pseudogene 5 |
8192 |
0.2 |
chr3_101517670_101517826 | 6.95 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
59812 |
0.09 |
chr13_48916144_48916308 | 6.92 |
Phf2 |
PHD finger protein 2 |
45107 |
0.13 |
chr8_114716669_114716838 | 6.91 |
Wwox |
WW domain-containing oxidoreductase |
4586 |
0.25 |
chr1_88064051_88064407 | 6.90 |
AC087801.2 |
UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), pseudogene |
3105 |
0.1 |
chr8_77369753_77369904 | 6.89 |
Gm45407 |
predicted gene 45407 |
2688 |
0.28 |
chr6_112939448_112939605 | 6.87 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
7228 |
0.15 |
chr8_111739071_111739223 | 6.85 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
4662 |
0.21 |
chr1_133302040_133302233 | 6.82 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
4185 |
0.14 |
chr5_8157542_8157699 | 6.82 |
Gm21759 |
predicted gene, 21759 |
22016 |
0.16 |
chr5_139359350_139359501 | 6.80 |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
4849 |
0.12 |
chr2_133768533_133768854 | 6.79 |
Gm25258 |
predicted gene, 25258 |
184272 |
0.03 |
chr8_125401526_125401692 | 6.74 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
91101 |
0.09 |
chr11_84440515_84440675 | 6.73 |
Aatf |
apoptosis antagonizing transcription factor |
8938 |
0.25 |
chr18_33214764_33214929 | 6.72 |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
984 |
0.69 |
chr7_43454103_43454267 | 6.72 |
Etfb |
electron transferring flavoprotein, beta polypeptide |
1295 |
0.18 |
chr11_97958258_97958415 | 6.71 |
Gm11633 |
predicted gene 11633 |
10456 |
0.1 |
chr4_3318688_3318877 | 6.66 |
Gm11786 |
predicted gene 11786 |
8393 |
0.21 |
chr10_34139889_34140096 | 6.61 |
Calhm6 |
calcium homeostasis modulator family member 6 |
12008 |
0.12 |
chr19_5028205_5028356 | 6.57 |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
2103 |
0.12 |
chr11_98766772_98767040 | 6.48 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3520 |
0.12 |
chr5_146114890_146115041 | 6.47 |
Cyp3a59 |
cytochrome P450, family 3, subfamily a, polypeptide 59 |
35698 |
0.09 |
chr6_145855716_145856207 | 6.47 |
Gm43909 |
predicted gene, 43909 |
7336 |
0.17 |
chr8_127185988_127186158 | 6.46 |
Pard3 |
par-3 family cell polarity regulator |
14669 |
0.27 |
chr7_66106744_66106923 | 6.45 |
Chsy1 |
chondroitin sulfate synthase 1 |
2682 |
0.17 |
chr7_130653140_130653305 | 6.45 |
4930513N20Rik |
RIKEN cDNA 4930513N20 gene |
1170 |
0.48 |
chr6_86129871_86130022 | 6.44 |
Gm19596 |
predicted gene, 19596 |
17206 |
0.14 |
chr18_38780704_38780880 | 6.44 |
Gm8302 |
predicted gene 8302 |
8445 |
0.2 |
chr1_88048809_88049389 | 6.43 |
Ugt1a10 |
UDP glycosyltransferase 1 family, polypeptide A10 |
6289 |
0.08 |
chr9_42508370_42508545 | 6.42 |
Tbcel |
tubulin folding cofactor E-like |
648 |
0.75 |
chr1_189993369_189993532 | 6.42 |
Smyd2 |
SET and MYND domain containing 2 |
71087 |
0.1 |
chr11_98766479_98766640 | 6.40 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3867 |
0.12 |
chr2_142699405_142699565 | 6.40 |
Kif16b |
kinesin family member 16B |
3186 |
0.35 |
chr16_95729140_95729334 | 6.38 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
11503 |
0.18 |
chr16_24091085_24091250 | 6.32 |
Gm31583 |
predicted gene, 31583 |
1078 |
0.5 |
chr6_82039277_82039610 | 6.31 |
Eva1a |
eva-1 homolog A (C. elegans) |
1600 |
0.34 |
chr5_99515852_99516005 | 6.29 |
Gm16227 |
predicted gene 16227 |
5246 |
0.22 |
chr3_149942137_149942288 | 6.25 |
Rpsa-ps10 |
ribosomal protein SA, pseudogene 10 |
131330 |
0.06 |
chr5_139395507_139395679 | 6.22 |
Gpr146 |
G protein-coupled receptor 146 |
5808 |
0.12 |
chr18_67210869_67211041 | 6.22 |
Gm50169 |
predicted gene, 50169 |
4985 |
0.15 |
chr5_113148745_113149067 | 6.19 |
Gm42161 |
predicted gene, 42161 |
3578 |
0.14 |
chr12_3835711_3835863 | 6.17 |
Dnmt3a |
DNA methyltransferase 3A |
13848 |
0.17 |
chr14_51871916_51872074 | 6.15 |
Mettl17 |
methyltransferase like 17 |
12847 |
0.08 |
chr15_38406150_38406330 | 6.13 |
Gm41307 |
predicted gene, 41307 |
2086 |
0.29 |
chr15_25942411_25942580 | 6.12 |
Retreg1 |
reticulophagy regulator 1 |
184 |
0.95 |
chr14_69325074_69325267 | 6.11 |
Gm16677 |
predicted gene, 16677 |
11912 |
0.09 |
chr13_36683697_36684027 | 6.09 |
Gm26395 |
predicted gene, 26395 |
29457 |
0.13 |
chr17_29322718_29322882 | 6.09 |
Gm46603 |
predicted gene, 46603 |
251 |
0.84 |
chr14_69543328_69543511 | 6.09 |
Gm27174 |
predicted gene 27174 |
11913 |
0.1 |
chr3_53000130_53000284 | 6.04 |
Cog6 |
component of oligomeric golgi complex 6 |
5522 |
0.16 |
chr9_83251916_83252091 | 6.04 |
Gm27216 |
predicted gene 27216 |
2019 |
0.35 |
chr16_95836091_95836242 | 6.02 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9604 |
0.18 |
chr19_29131769_29132065 | 6.01 |
Mir101b |
microRNA 101b |
3362 |
0.18 |
chr10_33994328_33994479 | 6.00 |
A830082N09Rik |
RIKEN cDNA A830082N09 gene |
651 |
0.53 |
chr6_90603381_90603563 | 5.96 |
Slc41a3 |
solute carrier family 41, member 3 |
1253 |
0.36 |
chr7_25220574_25220762 | 5.94 |
Dedd2 |
death effector domain-containing DNA binding protein 2 |
53 |
0.89 |
chr1_13266872_13267045 | 5.94 |
Gm27881 |
predicted gene, 27881 |
4760 |
0.15 |
chr5_111457663_111457990 | 5.90 |
Gm43119 |
predicted gene 43119 |
34237 |
0.14 |
chr5_136959042_136959193 | 5.90 |
Fis1 |
fission, mitochondrial 1 |
2960 |
0.13 |
chr11_118265609_118265912 | 5.89 |
Usp36 |
ubiquitin specific peptidase 36 |
288 |
0.89 |
chr14_30934111_30934339 | 5.87 |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
9052 |
0.1 |
chr9_122713984_122714139 | 5.86 |
Gm47136 |
predicted gene, 47136 |
272 |
0.8 |
chr9_110718913_110719073 | 5.84 |
Ccdc12 |
coiled-coil domain containing 12 |
8949 |
0.11 |
chr6_117577945_117578096 | 5.82 |
Gm9946 |
predicted gene 9946 |
10348 |
0.2 |
chrX_7911140_7911294 | 5.81 |
Gm10490 |
predicted gene 10490 |
1675 |
0.15 |
chr9_113121756_113121929 | 5.80 |
Gm36251 |
predicted gene, 36251 |
1187 |
0.61 |
chr14_67608406_67608577 | 5.77 |
Gm47010 |
predicted gene, 47010 |
19699 |
0.17 |
chr6_87424500_87424651 | 5.76 |
Bmp10 |
bone morphogenetic protein 10 |
4419 |
0.16 |
chr4_140620649_140620811 | 5.70 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
3665 |
0.23 |
chr10_80323047_80323198 | 5.70 |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
4 |
0.93 |
chr8_36031619_36031770 | 5.70 |
Rps12-ps24 |
ribosomal protein S12, pseudogene 24 |
5941 |
0.22 |
chr2_101827717_101827895 | 5.67 |
Prr5l |
proline rich 5 like |
11174 |
0.22 |
chr6_96536704_96536871 | 5.64 |
Gm26011 |
predicted gene, 26011 |
24077 |
0.25 |
chr17_63397757_63397920 | 5.64 |
Gm24813 |
predicted gene, 24813 |
50167 |
0.12 |
chr6_85261647_85261798 | 5.63 |
Sfxn5 |
sideroflexin 5 |
3211 |
0.22 |
chr2_160351084_160351266 | 5.62 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
15890 |
0.22 |
chr4_107999051_107999218 | 5.61 |
Slc1a7 |
solute carrier family 1 (glutamate transporter), member 7 |
10883 |
0.13 |
chr1_184093517_184093672 | 5.58 |
Dusp10 |
dual specificity phosphatase 10 |
59213 |
0.13 |
chr6_54120030_54120181 | 5.57 |
Chn2 |
chimerin 2 |
22385 |
0.18 |
chr2_169274428_169274663 | 5.56 |
9430093N23Rik |
RIKEN cDNA 9430093N23 gene |
39554 |
0.18 |
chr16_5184222_5184378 | 5.56 |
Nagpa |
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
13465 |
0.1 |
chr10_95616861_95617023 | 5.56 |
Gm33336 |
predicted gene, 33336 |
15297 |
0.12 |
chr7_134498863_134499014 | 5.55 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
46 |
0.99 |
chr5_63938757_63938940 | 5.54 |
Rell1 |
RELT-like 1 |
7934 |
0.17 |
chr11_16868200_16868447 | 5.52 |
Egfr |
epidermal growth factor receptor |
9827 |
0.2 |
chr8_114090720_114090885 | 5.49 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
42755 |
0.2 |
chr10_68256241_68256415 | 5.48 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
22393 |
0.21 |
chr4_8714834_8715372 | 5.47 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
4763 |
0.29 |
chr4_138186052_138186245 | 5.47 |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
1670 |
0.28 |
chr11_106528042_106528212 | 5.44 |
Gm22711 |
predicted gene, 22711 |
26882 |
0.13 |
chr1_134566100_134566265 | 5.43 |
Kdm5b |
lysine (K)-specific demethylase 5B |
5975 |
0.14 |
chr6_82997803_82997973 | 5.42 |
Gm43981 |
predicted gene, 43981 |
6243 |
0.08 |
chr4_149887083_149887262 | 5.40 |
Gm13070 |
predicted gene 13070 |
16834 |
0.13 |
chr8_84785963_84786162 | 5.40 |
Nfix |
nuclear factor I/X |
11693 |
0.1 |
chr19_42659668_42660167 | 5.39 |
Gm25216 |
predicted gene, 25216 |
39985 |
0.13 |
chr17_6959037_6959229 | 5.38 |
Tagap1 |
T cell activation GTPase activating protein 1 |
2023 |
0.21 |
chr17_31604512_31604663 | 5.36 |
Pknox1 |
Pbx/knotted 1 homeobox |
1849 |
0.18 |
chr3_10127624_10127791 | 5.36 |
Gm37308 |
predicted gene, 37308 |
37752 |
0.1 |
chr8_71316062_71316239 | 5.36 |
Myo9b |
myosin IXb |
17667 |
0.12 |
chr17_25648898_25649067 | 5.36 |
Gm22645 |
predicted gene, 22645 |
45238 |
0.05 |
chr5_117245335_117245486 | 5.34 |
Taok3 |
TAO kinase 3 |
4950 |
0.16 |
chr18_77823826_77823992 | 5.33 |
F830208F22Rik |
RIKEN cDNA F830208F22 gene |
27166 |
0.14 |
chr11_117970308_117970484 | 5.31 |
Socs3 |
suppressor of cytokine signaling 3 |
349 |
0.83 |
chr8_11055813_11056042 | 5.30 |
9530052E02Rik |
RIKEN cDNA 9530052E02 gene |
6349 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
4.5 | 13.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
4.3 | 12.9 | GO:0006868 | glutamine transport(GO:0006868) |
2.7 | 16.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
2.7 | 10.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.4 | 7.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.4 | 7.2 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.2 | 6.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.1 | 10.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
1.9 | 7.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.9 | 5.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.8 | 16.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.7 | 8.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.7 | 8.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 5.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 6.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.7 | 6.6 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
1.6 | 1.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.6 | 6.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.6 | 4.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.6 | 4.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 3.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.5 | 4.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.5 | 10.4 | GO:0060613 | fat pad development(GO:0060613) |
1.5 | 3.0 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
1.4 | 2.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.4 | 4.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.4 | 5.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.4 | 4.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.4 | 4.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.4 | 4.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.3 | 4.0 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.3 | 8.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 3.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.2 | 6.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.2 | 1.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.2 | 3.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.2 | 4.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.2 | 4.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.2 | 1.2 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
1.1 | 3.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.1 | 4.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 3.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.1 | 5.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 3.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.1 | 3.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 3.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
1.1 | 2.1 | GO:0070295 | renal water absorption(GO:0070295) |
1.1 | 4.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.1 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) glyoxylate metabolic process(GO:0046487) |
1.1 | 3.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.0 | 3.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.0 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.0 | 3.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.0 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 7.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.0 | 3.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.0 | 8.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 5.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 2.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 7.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.0 | 2.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 3.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.0 | 2.9 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.0 | 3.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.0 | 1.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.0 | 1.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.9 | 4.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 3.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 0.9 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 3.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.9 | 2.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.9 | 5.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.9 | 24.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.9 | 0.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.9 | 4.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.9 | 2.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 4.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.9 | 2.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.9 | 2.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 2.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 3.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.9 | 2.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 3.4 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.8 | 3.4 | GO:0009750 | response to fructose(GO:0009750) |
0.8 | 5.9 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.8 | 6.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 2.5 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.8 | 2.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.8 | 3.3 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.8 | 0.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.8 | 2.5 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.8 | 2.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 3.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.8 | 4.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 1.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.8 | 0.8 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) marginal zone B cell differentiation(GO:0002315) |
0.8 | 4.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.8 | 1.6 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 2.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.8 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 1.6 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.8 | 1.6 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.8 | 2.3 | GO:0015791 | polyol transport(GO:0015791) |
0.8 | 2.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.8 | 3.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.8 | 6.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.8 | 5.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.8 | 1.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.8 | 2.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.8 | 3.1 | GO:0050955 | thermoception(GO:0050955) |
0.8 | 1.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.8 | 0.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 3.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.7 | 3.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 2.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 1.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 2.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 2.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.7 | 1.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.7 | 4.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 1.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 4.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 2.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 2.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.7 | 0.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 1.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.7 | 2.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 2.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.7 | 2.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.7 | 4.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 2.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 2.8 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.7 | 5.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.7 | 6.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.7 | 2.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 2.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 5.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 2.7 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.7 | 1.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.7 | 2.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.7 | 5.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 5.4 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.7 | 5.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 2.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.7 | 2.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 1.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 6.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 1.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.7 | 1.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.7 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 1.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.6 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 3.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 2.6 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 3.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 2.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 2.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 2.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 1.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 2.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 2.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 2.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 5.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 2.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 2.5 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.6 | 0.6 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.6 | 2.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 6.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.6 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 1.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 0.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 1.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 2.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.6 | 4.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 1.8 | GO:0015819 | lysine transport(GO:0015819) |
0.6 | 1.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.6 | 1.8 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 3.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.6 | 1.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.6 | 4.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 1.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 4.1 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 8.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.6 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 2.9 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.6 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.6 | 1.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 2.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 1.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 1.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.6 | 1.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 2.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.6 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 5.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 4.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 2.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 5.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 2.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 3.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.6 | 4.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.6 | 1.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.6 | 1.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.6 | 1.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 3.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.5 | 2.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 2.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 7.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.5 | 3.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 1.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 2.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 7.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 1.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.1 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.5 | 5.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 3.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 6.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.5 | 0.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.5 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 1.0 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.5 | 8.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 1.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 0.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 1.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 2.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 1.0 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 1.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 1.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 2.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 1.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 1.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.5 | 1.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 2.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.5 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 3.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 1.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 1.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 2.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 2.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 1.9 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.5 | 1.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 1.9 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 2.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 2.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 0.9 | GO:0002434 | immune complex clearance(GO:0002434) |
0.5 | 1.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 2.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 5.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 2.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 6.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.5 | 2.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 1.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 3.7 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.5 | 2.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 0.9 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.5 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.5 | 2.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 3.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 2.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 0.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 0.4 | GO:0070875 | regulation of glycogen catabolic process(GO:0005981) positive regulation of glycogen metabolic process(GO:0070875) |
0.4 | 1.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 0.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 1.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 0.9 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 2.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 4.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 1.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 4.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.4 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.4 | 3.9 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 2.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 0.4 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.4 | 2.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.7 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.4 | 2.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 1.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 1.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 0.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.4 | 1.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 2.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 0.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.4 | 0.4 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.4 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 4.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.4 | 1.3 | GO:0050954 | sensory perception of mechanical stimulus(GO:0050954) |
0.4 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 5.9 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 1.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 0.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 7.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 1.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.4 | 1.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 0.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 2.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 2.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 0.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.4 | 2.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 1.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 1.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 1.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 4.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 0.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 5.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 3.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 2.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 2.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 1.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 7.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 1.6 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.4 | 1.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 0.8 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 2.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.4 | 1.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 3.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.4 | 0.4 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.4 | 0.8 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.4 | 1.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 2.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.4 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.4 | 1.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.4 | 3.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 1.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 3.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 | 1.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 0.4 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 6.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 5.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 2.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 2.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 3.0 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 0.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 1.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.4 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 0.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 1.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 1.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 1.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 1.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.4 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.4 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 8.4 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.4 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 | 0.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 2.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 2.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 0.4 | GO:0015840 | urea transport(GO:0015840) |
0.4 | 7.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 2.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 2.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 10.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 0.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 0.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.3 | 6.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 2.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.3 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 1.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 1.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 1.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 1.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.3 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 2.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 3.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 3.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 1.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.7 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 4.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.3 | 3.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 2.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 3.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 1.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 3.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 2.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 0.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.3 | 0.3 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 11.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 1.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 2.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 3.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.3 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.3 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 0.3 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.3 | 2.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.3 | 0.9 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 2.5 | GO:0034030 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.3 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 4.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.3 | 0.3 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 0.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 2.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 0.9 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 1.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 2.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 2.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 6.7 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.3 | 0.6 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 4.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.5 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 3.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 1.5 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.5 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.3 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.3 | 0.6 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.3 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 0.9 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.3 | 1.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 1.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.3 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.3 | 7.7 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.9 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.6 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.3 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 3.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 6.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 2.9 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.3 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 1.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 7.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 4.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 1.1 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.3 | 0.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.6 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 1.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 1.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 0.8 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.3 | 0.8 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 0.6 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.3 | 0.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 1.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.3 | 0.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 1.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 1.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.3 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 2.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 4.4 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.3 | 1.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 1.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 2.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 1.9 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 21.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.5 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 1.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.1 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.3 | 0.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.3 | 4.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 1.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.3 | 1.3 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 2.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 1.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.8 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 1.6 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 1.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 5.7 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 2.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.3 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.3 | 1.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 1.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 3.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 1.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 0.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 6.7 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.7 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.7 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 2.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 2.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 2.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.7 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.5 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.2 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.2 | 1.5 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.2 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 1.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.5 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.2 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 1.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.2 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.2 | 2.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 3.1 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 0.9 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.2 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.2 | 1.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 2.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.1 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.2 | 2.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 2.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.4 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 2.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 2.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.7 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.6 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 1.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 1.9 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 2.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.2 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.2 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 1.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.6 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 0.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 2.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 1.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 17.6 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.4 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.2 | 0.4 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 1.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 2.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 9.1 | GO:0015758 | glucose transport(GO:0015758) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 3.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.6 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 1.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 4.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 2.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.2 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 1.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.2 | GO:1901858 | regulation of mitochondrial DNA replication(GO:0090296) regulation of mitochondrial DNA metabolic process(GO:1901858) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 3.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.2 | GO:0071428 | rRNA export from nucleus(GO:0006407) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 1.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 1.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 2.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 9.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 1.4 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 1.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.5 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 1.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 1.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 1.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 1.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.2 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.7 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 1.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 3.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 8.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.8 | GO:2000269 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.8 | GO:0048678 | response to axon injury(GO:0048678) |
0.2 | 0.3 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.2 | 3.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 2.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 3.0 | GO:0002209 | behavioral defense response(GO:0002209) |
0.2 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.9 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 2.8 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 8.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.6 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.2 | 0.5 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.3 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 2.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 0.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.8 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.2 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 2.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.6 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 3.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.1 | 1.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 1.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.3 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 1.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.4 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 7.3 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.5 | GO:0046794 | transport of virus(GO:0046794) |
0.1 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.4 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 2.1 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.1 | GO:0014857 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 1.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.5 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 1.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.7 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 3.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 1.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.0 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 1.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 1.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 3.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 1.6 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 1.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 5.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.9 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 1.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 1.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 2.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.6 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 1.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 1.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 1.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 1.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.5 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.7 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0048857 | neural nucleus development(GO:0048857) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.6 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.1 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:2001055 | endothelial cell fate specification(GO:0060847) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.3 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 6.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.1 | 0.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.1 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 0.8 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 1.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.3 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.1 | 1.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.7 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.3 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.3 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.7 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 1.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:0030510 | regulation of BMP signaling pathway(GO:0030510) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.4 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 1.0 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.1 | 1.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.9 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 4.8 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.8 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.1 | 0.5 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 2.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 4.3 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
0.1 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 2.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.9 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 1.6 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 1.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 1.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.2 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.1 | 0.1 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.9 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.1 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 1.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 1.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.8 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.1 | GO:1902106 | negative regulation of leukocyte differentiation(GO:1902106) |
0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.0 | GO:0072526 | pyridine nucleotide catabolic process(GO:0019364) pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.3 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.0 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.0 | 0.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.0 | 0.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.0 | 0.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.7 | GO:0098773 | skin epidermis development(GO:0098773) |
0.0 | 0.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 1.8 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.9 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0045058 | T cell selection(GO:0045058) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 0.0 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0001708 | cell fate specification(GO:0001708) |
0.0 | 0.0 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.2 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 0.0 | GO:0097009 | energy homeostasis(GO:0097009) |
0.0 | 0.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.8 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.0 | GO:0086065 | cell communication involved in cardiac conduction(GO:0086065) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0061337 | cardiac conduction(GO:0061337) |
0.0 | 0.0 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 11.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0002335 | mature B cell differentiation(GO:0002335) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.6 | 7.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.6 | 7.8 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 6.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.5 | 5.8 | GO:0042583 | chromaffin granule(GO:0042583) |
1.4 | 5.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.4 | 8.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 4.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.3 | 16.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.2 | 1.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.1 | 3.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.1 | 5.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 4.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.1 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 3.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.0 | 10.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.0 | 9.2 | GO:0097542 | ciliary tip(GO:0097542) |
1.0 | 3.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 3.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 3.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 6.2 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 3.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 2.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 2.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 2.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.8 | 5.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.8 | 2.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 0.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.8 | 2.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 8.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 2.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.8 | 7.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 2.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 2.9 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 5.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 4.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 2.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 6.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 3.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 1.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 9.2 | GO:0001741 | XY body(GO:0001741) |
0.6 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 4.7 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 0.6 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.6 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 1.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 2.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 7.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.6 | 11.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.5 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 2.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 5.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 0.5 | GO:0005767 | secondary lysosome(GO:0005767) phagolysosome(GO:0032010) |
0.5 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 2.6 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 7.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 3.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 0.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.5 | 4.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 4.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 12.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 1.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 5.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 2.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 3.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 2.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 2.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 1.3 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 1.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 3.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 4.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.4 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 7.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.1 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 7.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 2.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 2.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 4.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 10.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 3.8 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 1.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 3.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 2.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 6.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 5.6 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 2.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.4 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 4.8 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 1.3 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 3.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 6.3 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 2.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 18.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 3.5 | GO:0033646 | host intracellular part(GO:0033646) intracellular region of host(GO:0043656) |
0.3 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 16.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 16.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 1.5 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 8.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 1.5 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 0.9 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 2.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 3.5 | GO:0043034 | costamere(GO:0043034) |
0.3 | 2.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 4.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 1.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.3 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 1.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 1.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 5.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 7.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 2.7 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 1.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 10.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 2.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 22.5 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 3.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 13.5 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 9.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 18.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.2 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 4.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 3.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 8.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 2.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 1.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 5.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.9 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 1.6 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 17.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 25.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 2.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 2.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.3 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 6.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 1.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 3.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.8 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 5.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 39.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.3 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 2.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 4.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 15.7 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 2.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 3.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 99.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 5.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 11.9 | GO:0070161 | anchoring junction(GO:0070161) |
0.1 | 2.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 1.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 2.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 2.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 2.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 4.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 5.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 7.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.5 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 1.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 4.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 7.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 3.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 2.3 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 2.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 3.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 2.9 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 18.7 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 46.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 22.2 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 3.5 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 66.0 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 12.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 1.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.3 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 1.5 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.4 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 1.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 41.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 27.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 55.1 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
4.3 | 13.0 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.4 | 10.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.1 | 6.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.9 | 1.9 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.9 | 5.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.8 | 5.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.8 | 7.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.8 | 3.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.7 | 5.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 6.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.6 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.4 | 7.0 | GO:0070061 | fructose binding(GO:0070061) |
1.4 | 4.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.4 | 5.4 | GO:0015265 | urea channel activity(GO:0015265) |
1.3 | 7.7 | GO:0043426 | MRF binding(GO:0043426) |
1.3 | 9.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.3 | 6.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.2 | 3.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 3.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.2 | 6.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.2 | 7.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.2 | 3.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.1 | 5.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.1 | 3.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 13.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.1 | 10.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.1 | 3.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 5.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 3.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.0 | 11.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.0 | 3.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 3.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.0 | 2.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 2.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.9 | 2.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 2.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.9 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 4.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.9 | 0.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.9 | 4.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 4.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.9 | 4.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 6.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 2.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 7.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 2.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 2.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.8 | 2.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.8 | 2.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 4.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.8 | 4.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.8 | 2.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 6.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.8 | 2.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.8 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.8 | 0.8 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.8 | 2.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 3.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.8 | 6.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.7 | 4.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 2.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 6.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 2.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 30.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.7 | 3.4 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 2.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 3.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 24.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.7 | 8.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 3.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.7 | 2.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 11.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 1.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.6 | 4.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 11.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 3.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 2.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 3.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.6 | 6.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 3.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.6 | 1.8 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.6 | 6.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.6 | 1.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.6 | 8.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 4.6 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 1.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.6 | 2.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 4.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 1.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 3.3 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 2.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 1.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 3.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 0.5 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.5 | 1.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 4.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 17.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 1.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 6.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 2.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 2.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 4.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 4.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 5.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 2.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.5 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 5.5 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 4.0 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.5 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 1.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 4.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 14.0 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.5 | 3.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.5 | 1.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 2.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 1.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 1.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 2.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 5.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 1.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 6.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 3.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 4.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 1.8 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 10.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 3.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 1.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 6.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 4.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 2.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 0.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 12.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 3.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 1.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 8.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 2.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 2.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 2.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 4.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 19.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 2.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 4.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 6.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 4.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 1.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 1.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 0.4 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.4 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 4.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 10.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 8.7 | GO:0009975 | cyclase activity(GO:0009975) |
0.4 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 2.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 8.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 1.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.4 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 3.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 12.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 1.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.4 | 0.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 1.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 3.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 0.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 4.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 2.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 2.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 4.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 2.7 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 1.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 6.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 2.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 7.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 5.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 2.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 12.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 4.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 5.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 2.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 4.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 7.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.8 | GO:0070251 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 2.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 6.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 4.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 3.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 2.1 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 3.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 11.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 1.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 3.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 2.3 | GO:0034821 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 3.2 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 1.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 1.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 7.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 2.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 7.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 1.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 2.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 3.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 3.6 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 4.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.3 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.3 | 2.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 13.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 5.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 10.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 1.4 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.2 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 4.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.9 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 9.5 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 1.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 3.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 2.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 48.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 1.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 1.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 15.2 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 1.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 2.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 5.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 8.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 3.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 3.0 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.6 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 6.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 3.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 3.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 2.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 6.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 2.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 4.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 3.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 1.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 8.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 4.3 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 9.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 2.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 18.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 3.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 2.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 2.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 12.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 2.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 4.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 11.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 15.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 3.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 2.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 2.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 2.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 3.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 3.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 20.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 13.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 8.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 5.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.8 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 1.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 14.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 2.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 6.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 3.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 2.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 5.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 2.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 2.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 2.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 5.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.8 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 4.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 1.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 2.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
0.0 | 1.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 1.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0070325 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 5.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 2.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 10.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 24.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 10.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 8.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 14.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 4.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 9.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 39.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 19.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 18.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 1.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 6.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 10.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 12.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 10.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 4.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 18.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 8.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 8.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 11.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 3.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 3.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 2.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 8.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 5.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 3.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 14.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 5.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 6.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 5.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 4.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 11.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 6.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 11.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 3.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 13.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 2.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 1.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 6.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 4.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 4.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 4.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 3.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 5.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.0 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 7.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 4.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 4.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 3.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 11.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 15.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 11.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 8.2 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 3.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.5 | 4.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.4 | 23.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.1 | 4.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 1.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.9 | 21.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.8 | 8.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 8.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 5.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 9.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 7.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 6.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 6.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 15.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.6 | 4.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 15.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.6 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 13.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 6.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 6.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 9.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 5.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 5.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 8.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 3.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 6.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 3.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 1.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 5.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 4.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 14.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 10.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 6.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 4.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 5.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 19.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 4.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.4 | 3.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 7.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 3.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 2.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 8.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 3.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 7.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 5.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 4.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 1.8 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 4.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 3.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 2.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 2.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 5.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 16.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 2.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 6.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 5.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 20.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 2.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 2.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 21.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 4.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 5.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 2.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 20.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 3.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 9.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 8.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 5.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 8.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 2.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 9.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 5.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 0.4 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 6.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 1.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 3.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 4.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 5.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 6.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.7 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 9.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 4.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 4.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 0.3 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 6.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 5.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.6 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 6.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.8 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |